Intake of Selected Micronutrients and the Risk of Surgically Treated Benign Prostatic Hyperplasia: A Case-Control Study from Italy

European Urology

Volumn 50, Issue 3, 2006, Pages 549-554

  Tavani, Alessandra ^a   Longoni, Elisa ^a   Bosetti, Cristina ^a   Maso, Luigino Dal ^b   Polesel, Jerry ^b   Montella, Maurizio ^c   Ramazzotti, Valerio ^d   Negri, Eva ^a   Franceschi, Silvia ^e   Vecchia, Carlo La ^a,f  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Antioxidants; Benign prostatic hyperplasia; Micronutrients; Risk factors; Vitamins

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENE; FOLIC ACID; IRON; LYCOPENE; RETINOL; SODIUM; TRACE ELEMENT; VITAMIN D; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EDUCATION; HOSPITAL ADMISSION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTECTION; QUESTIONNAIRE; RISK; VITAMIN INTAKE;

ADULT; AGED; CAROTENOIDS; CASE-CONTROL STUDIES; EATING; EDUCATIONAL STATUS; FOOD HABITS; HUMANS; ITALY; MALE; MICRONUTRIENTS; MIDDLE AGED; PROSTATIC HYPERPLASIA; RISK FACTORS; SOCIAL CLASS;

EID: 33746903598     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.11.027     Document Type: Article

References (30)

1. Schmidt A., Sommer F., Ozgur E., Klotz T., Engelmann U., Addicks K., and Bloch W. Vessels in benign prostatic hyperplasia contain more binding sites for endostatin than vessels in normal prostate tissue. Eur Urol 46 (2004) 765-767
2. Marberger M., Harkaway R., and de la Rosette J. Optimising the medical management of benign prostatic hyperplasia. Eur Urol 45 (2004) 411-419
3. Guess H.A. Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 14 (1992) 131-153
4. Neuhouser M.L., Kristal A.R., and Penson D.F. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature. Urology 64 (2004) 201-211
5. Andersson S., Berman D.M., Jenkins E.P., and Russell D.W. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354 (1991) 159-161
6. Frydenberg M., Foo T.M., Jones A.S., Grace J., Hensley W.J., Rogers J., et al. Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expression. J Urol 146 (1991) 872-876
7. McConnell J.D., Bruskewitz R., Walsh P., Andriole G., Lieber M., Holtgrewe H.L., et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 338 (1998) 557-563
8. Thomas J.A. Diet, micronutrients, and the prostate gland. Nutr Rev 57 (1999) 95-103
9. Lagiou P., Wuu J., Trichopoulou A., Hsieh C.-C., Adami H.-O., and Trichopoulos D. Diet and benign prostatic hyperplasia: a study in Greece. Urology 54 (1999) 284-290
10. Franceschi S., Barbone F., Negri E., Decarli A., Ferraroni M., Filiberti R., et al. Reproducibility of an Italian food frequency questionnaire for cancer studies. Results for specific nutrients. Ann Epidemiol 5 (1995) 69-75
11. Decarli A., Franceschi S., Ferraroni M., Gnagnarella P., Parpinel M.T., La Vecchia C., et al. Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy: results for specific nutrients. Ann Epidemiol 6 (1996) 110-118
12. Crispo A., Talamini R., Gallus S., Negri E., Gallo A., Bosetti C., et al. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia. Urology 64 (2004) 717-722
13. Zucchetto A., Tavani A., Dal Maso L., Gallus S., Negri E., Talamini R., et al. History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes 29 (2005) 798-803
14. Madersbacher S., Alivizatos G., Nordling J., Sanz C.R., Emberton M., and de la Rosette J.J.M.C.H. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46 (2004) 547-554
15. Salvini S, Parpinel M, Gnagnarella P, Maisonneuve P, Turrini A. Banca dati di composizione degli alimenti per studi epidemiologici in Italia. Milano: Istituto Europeo di Oncologia, 1998.
16. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. I. The analysis of case-control studies. Lyon, France, IARC, 1980. IARC Science Publication no. 32.
17. Souverein P.C., van Riemsdijk M.M., de la Rosette J.J.M.C.H., Opdam P.C., and Leufkens H.G.M. Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: a population-based cohort study in the Netherlands. Eur Urol 47 (2005) 505-510
18. Tubaro A., La Vecchia C., and for the Uroscreening Study Group. The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey. Eur Urol 45 (2004) 767-772
19. Zaichick V.Y.e., Sviridova T.V., and Zaichick S.V. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29 (1997) 565-574
20. Lahtonen R. Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign prostatic hypertrophic glands. Prostate 6 (1985) 177-183
21. Wilson J.D. The pathogenesis of benign prostatic hyperplasia. Am J Med. 68 (1980) 745-756
22. Leake A., Chrisholm G.D., Busuttil A., and Habib F.K. Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction. Acta Endocrinol 105 (1984) 281-288
23. Steinmetz K.A., and Potter J.D. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 2 (1991) 427-442
24. Clinton S.K. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 56 (1998) 35-51
25. Favero A., Salvini S., Russo A., Parpinel M.T., Negri E., Decarli A., et al. Sources of macro- and micronutrients in Italian women: results from a food frequency questionnaire for cancer studies. Eur J Cancer Prev 6 (1997) 277-287
26. Morrison A.S. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135 (1992) 974-980
27. Chyou P.H., Nomura A.M., Stemmermann G.N., and Hankin J.H. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 22 (1993) 253-264
28. Platz E.A., Rimm E.B., Kawachi I., Colditz G.A., Stampfer M.J., Willett W.C., et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 149 (1999) 106-115
29. Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 90 (2002) 649-654
30. Kang D., Andriole G.L., van de Vooren R.C., Crawford D., Chia D., Urban D.A., et al. Risk behaviours and benign prostatic hyperplasia. BJU Int 93 (2004) 1241-1245